Ierland - Engels - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - calcium chloride hexahydrate, magnesium sulfate, potassium chloride, thiamine hydrochloride, riboflavin sodium phosphate, pyridoxine hydrochloride, cyanocobalamin, nicotinamide, dexpanthenol, glucose anhydrous, arginine hydrochloride, cysteine hydrochloride monohydrate, histidine hydrochloride, isoleucine, leucine, lysine hydrochloride, methionine, phenylalanine, threonine, tryptophan, dl, valine, monosodium l-glutamate monodydrate - solution for injection - unknown - solutions affecting the electrolyte balance - bovine, canine, equine - food, feline, porcine - electrolytes

Filipijnen - Engels - FDA (Food And Drug Administration)

buergli pharma inc.; distributor: medchoice endocrine group inc. - alendronic acid , calcium citrate/cholecalciferol (vitamin d3) - film-coated tablet - 70mg (equivalent to alendronate monosodium trihydrate 91.37 mg)/1.5g/200 iu

Ierland - Engels - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - calcium chloride hexahydrate, magnesium sulfate, potassium chloride, thiamine hydrochloride, riboflavin sodium phosphate, pyridoxine hydrochloride, cyanocobalamin, nicotinamide, dexpanthenol, glucose anhydrous, arginine hydrochloride, cysteine hydrochloride monohydrate, histidine hydrochloride, isoleucine, leucine, lysine hydrochloride, methionine, phenylalanine, threonine, tryptophan, dl, valine, monosodium l-glutamate monodydrate - solution for injection - solutions affecting the electrolyte balance - bovine, canine, equine - food, feline, porcine - electrolytes

Verenigde Staten - Engels - NLM (National Library of Medicine)

liddell laboratories, inc. - alanine (unii: of5p57n2zx) (alanine - unii:of5p57n2zx), arginine (unii: 94zla3w45f) (arginine - unii:94zla3w45f), asparagine (unii: 5z33r5tko7) (asparagine - unii:5z33r5tko7), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), monosodium glutamate anhydrous (unii: c3c196l9fg) (monosodium glutamate anhydrous - unii:c3c196l9fg), glutamine (unii: 0rh81l854j) (glutamine - unii:0rh81l854j), glycine (unii: te7660xo1c) (glycine - unii:te7660xo1c), histidine (unii: 4qd397987e) (histidine - unii:4qd39 - alanine 6 [hp_x] in 1 ml -   may temporarily help improve overall health and growth hormone production. may temporarily help improve overall health and growth hormone production.

Verenigde Staten - Engels - NLM (National Library of Medicine)

deseret biologicals, inc. - chelidonium majus 3x, phytolacca decandra 3x, arnica montana 6x, 12x, 30x, 200x, nitricum acidum 12x, nux vomica 12x, phosphoricum acidum 12x, bisphenol a (bpa) 12x, 30x, 200x, dextrose 12x, 30x, 200x, maltodextrin 12x, 30x, 200x, sucralose 12x 30x, 200x, aspartic acid 30x, 60x, 200x, diketopiperazine 30x, 60x, 200x, dopamine 30x, 60x, 200x, formalinum 30x, 60x, 200x, formicum acidum 30x, 60x, 200x, methyl alcohol 30x, 60x, 200x, monosodium glutamate 30x, 60x, 200x, phenylalanine 30x, 60x, 200x -

Bangladesh - Engels - DGDA (Directorate General of Drug Administration)

globe pharmaceuticals ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Bangladesh - Engels - DGDA (Directorate General of Drug Administration)

guardian healthcare ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Bangladesh - Engels - DGDA (Directorate General of Drug Administration)

orion infusion ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Bangladesh - Engels - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - calcium chloride + d-pantothenol + dl-methionine + dextrose + l-arginine hcl + l-cysteine hcl + l-histidine hcl + l-isolencine + l-leucine + l-lysine hcl + l-phenylalamine + l-threonine + l-tryptophane + l-valine + magnesium sulphate + monosodium glutamate + nicotinamide + potassium chloride + pyridoxine + riboflavin + sodium acetate + thiamine hydrochloride - injection - 2 mg + .1 mg + .525 mg + 50 mg + 1.425 mg + .02 mg + .02 mg + .525 mg + .6 mg + .525 mg + .35 mg + .35 mg + .175 mg + .525 mg + 2 mg + .08 mg + 3 mg + 2 mg + .1 mg + .05 mg + 7.5 mg + .1 mg/ml

Australië - Engels - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ranitidine hydrochloride, quantity: 168 mg (equivalent: ranitidine, qty 150 mg) - tablet, effervescent - excipient ingredients: sodium benzoate; povidone; sodium bicarbonate; monosodium dihydrogen citrate; aspartame; flavour - short term treatment of proven duodenal and gastric ulcer. maintenance treatment to reduce the risk of relapse in duodenal ulcer. maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. treatment of gastrinoma (zollinger-ellison syndrome). short-term symptomatic treatment of reflux oesophagitis unresponsive to conservative anti-reflux measures and simple drug therapies such as antacids. treatment of scleroderma oesophagitis. new indications as at 2 november 1993: 1. short-term treatment of proven duodenal ulcer and gastric ulcer, including intravenous use for prophylaxis against recurrent haemorrhage. 2. maintenance treatment to reduce the risk of relapse in duodenal ulcer. 3. maintenance treatment for periods up to one year to reduce the risk of relapse in patients with documented healing of benign gastric ulcer. 4. treatment of gastrinoma (zollinger-ellison syndrome). 5. short- term symptomatic treatment of reflux oe